Themis Bioscience Competitors and Similar CompaniesClear all

Themis Bioscience's competitors and similar companies include Medisun Precision Medicine, Cell Genesys, Vitrolife and Fulcrum Therapeutics.
Themis Bioscience
Themis Bioscience
Themis Bioscience develops vaccines against tropical infections.
Medisun Precision Medicine
Medisun Precision Medicine
Medisun Precision Medicine (formerly Accurexa) is a biotechnology company focused on targeted delivery of therapies to affected areas of a patient's body through the use of innovative technologies.
Cell Genesys
Cell Genesys
Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today.
Vitrolife
Vitrolife
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.
Fulcrum Therapeutics
Fulcrum Therapeutics
We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
Founding Date
Founding Date
2009
Founding Date
2012
Founding Date
1988
Founding Date
1981
Founding Date
2016
Type
Type
Subsidiary
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Wien, AT HQ
Locations
Newark, US HQ
Locations
Roosevelt, US HQ
Locations
Västra Frölunda, SE HQ
Locations
Cambridge, US HQ
Employees
Employees
373% decrease
Employees
3
Employees
89
Employees
1,150
Employees
43223% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
6.4 k
Valuation ($)
N/A
Valuation ($)
3.1 b
Valuation ($)
202.2 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
kr3.4b (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($1.9m) (FY, 2016)
Net income
N/A
Net income
(kr5b) (FY, 2025)
Net income
($74.9m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 81.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 55m
For sources of this data, please see the company profile

View Company Profiles

Medisun Precision Medicine
HQ
Newark, US
Employees
3

Medisun Precision Medicine (formerly Accurexa) is a biotechnology company focused on targeted delivery of therapies to affected areas of a patient's body through the use of innovative technologies.

View company
Cell Genesys
HQ
Roosevelt, US
Employees
89

Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today.

View company
Vitrolife
HQ
Västra Frölunda, SE
Employees
1,150

Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.

View company
Fulcrum Therapeutics
HQ
Cambridge, US
Employees
432↑ 23% increase

We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.

View company